Scientists have identified blood proteins associated with aging of the brain and heart
- Новости
- Health
- Scientists have identified blood proteins associated with aging of the brain and heart
The condition of the cerebral vessels affects not only the risk of stroke, but also memory, thinking and other cognitive functions. The researchers found four proteins in the blood, the levels of which are associated with damage to brain vessels, deterioration of cognitive performance and adverse cardiovascular events. The data obtained can help in the development of additional ways to assess health risks. About which molecules turned out to be important and why their study can change the approach to assessing the state of the brain — in the material "Izvestia".
Cerebrovascular diseases are a group of disorders associated with damage to the blood vessels of the brain. They can lead to brain tissue damage, microbleeds, and white matter changes, as well as increase the risk of stroke, cognitive decline, and dementia.
More than 1 thousand proteins under supervision
A study by specialists from the National University of Singapore has been published in the journal Alzheimer's & Dementia: The Journal of the Alzheimers Association (A&D). The researchers studied the data of 518 people who were examined at the memory clinic. The average age of the participants was about 73 years. The researchers simultaneously assessed blood composition, performed an MRI scan of the brain, and checked cognitive functions.
Using proteomic analysis, the scientists measured the concentration of 1,441 proteins in blood plasma. Then, the data obtained were compared with signs of cerebrovascular damage: changes in white matter, lacunar infarcts, microbleeds, and cortical infarcts. Repeated MRI scans allowed us to track which protein parameters are associated not only with pre-existing changes, but also with their progression over the course of four years.
The analysis revealed many proteins associated with various types of vascular damage. They were involved in the processes of inflammation, immune response, cell interaction, and blood clotting. The researchers then identified four molecules that proved to be particularly significant in assessing the association between vascular changes in the brain, cognitive decline, and subsequent adverse events.
Sim Min Ann, the first author of the study
By studying more than 1,400 proteins simultaneously and comparing them with changes on MRI over several years, we gained a broader understanding of the biological processes associated with cerebrovascular diseases, and identified proteins associated with both current disorders and future health consequences.
Which proteins turned out to be important
The final group included four proteins: NEFL, LTBP2, PLAUR, and CRIM1. They are associated with different biological processes. NEFL is a component of the internal framework of nerve cells that can enter the bloodstream when their processes are damaged. LTBP2 is involved in interactions with extracellular matrix components. PLAUR is associated with the regulation of cellular interaction and adhesion, while CRIM1 is associated with the maintenance of vascular balance.
The researchers found that the combination of these proteins helps explain part of the relationship between vascular brain damage and subsequent cognitive decline. The most prominent role in this connection was played by NEFL, which reflects damage to nerve cells. The remaining molecules complemented the picture, indicating processes related to the state of blood vessels and cell interaction.
It is important that scientists do not claim that these proteins cause brain damage on their own. Their concentration may reflect changes already occurring in the nervous tissue, blood vessels, and other biological systems. Therefore, we are talking about potential biomarkers that help assess the condition of the body, and not about proven causes of diseases.
Association with cardiovascular events and mortality
In addition to changes in MRI and cognitive parameters, the scientists assessed whether the detected proteins were associated with serious cardiovascular and cerebrovascular events. In the first group, such events occurred in 30 people during the follow-up period, and 47 participants died. The increased values of individual proteins made it possible to assess the likelihood of adverse outcomes, taking into account age, gender, education, and a number of health factors.
The researchers then tested the results on an independent sample of 2016 people. In this group, four proteins were also found to be associated with mortality risk. Thus, the molecular signature received additional confirmation beyond the initial group of patients at the memory clinic.
The head of the study, Professor Christopher Chen, noted that cerebrovascular diseases significantly contribute to cognitive decline and the development of dementia. According to him, the discovery of proteins associated with brain changes and future cardiovascular consequences may bring scientists closer to more accurately identifying risk groups.
Is it possible to assess brain health by blood test
The authors suggest that in the future, blood protein analysis will be able to complement MRI and traditional clinical indicators in assessing the risk of vascular and cognitive disorders. This approach will potentially make it possible to identify people who need more careful monitoring, including before the appearance of pronounced damage to brain tissue or a noticeable deterioration in memory and thinking.
Christopher Chen
Our long—term goal is to develop more accurate and clinically useful tools that will identify people at high risk before significant brain damage or cognitive decline occurs. If further tested, markers in the blood can potentially complement existing assessment methods and help doctors more accurately adapt monitoring and prevention strategies to each individual's needs.
At the same time, the study does not yet provide a ready-made test for diagnosis or an individual prognosis. The first group consisted of patients from the Memory Clinic in Singapore, and an independent sample was used primarily to test the association of proteins with mortality. Therefore, the results need to be confirmed in other populations and in larger studies.
Scientists will also have to figure out what role each of the four molecules plays in the development of vascular damage and cognitive impairment. So far, the work shows, first of all, a stable statistical relationship between protein indicators and health status. In the future, such markers may become an additional tool for risk assessment, but they are not yet able to replace a full-fledged examination.
Переведено сервисом «Яндекс Переводчик»